Nyxoah SA Corporate Analyst Meeting Transcript
All right. I would like to welcome everyone to Nyxoah's inaugural investor announcement here in New York City. So forward-looking statements, which everyone here knows. We're really honored today to have 3 leading sleep clinicians here with us. So ladies first, Dr. Maria Suurna from the University of Miami. And then we have Dr. Maurits Boon from Thomas Jefferson University; and Dr. David Kent from Vanderbilt University.
All right. So in terms of the agenda, we're going to start off with the Nyxoah journey. Opening will be Olivier Taelman, Chief Executive Officer. And then we'll move into hypoglossal nerve stimulation and the Genio solution from Professor Boon. Maria will touch on how we're looking to expand the OSA market or HGNS OSA market between complete concentric collapse patients. And then Dr. Kent is going to touch on ansa cervicalis and the ability to treat patients right now that are not responsive to HGNS. Then we'll have closing remarks, question and answers and a cocktail reception.
And before I turn it over to Olivier, just one more person who's
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
